The Predictive Capabilities of Artificial Intelligence-Based OCT Analysis for Age-Related Macular Degeneration Progression-A Systematic Review.
age-related macular degeneration
deep learning
machine learning
prediction
progression
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
24 Jul 2023
24 Jul 2023
Historique:
received:
15
05
2023
revised:
16
06
2023
accepted:
13
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
The era of artificial intelligence (AI) has revolutionized our daily lives and AI has become a powerful force that is gradually transforming the field of medicine. Ophthalmology sits at the forefront of this transformation thanks to the effortless acquisition of an abundance of imaging modalities. There has been tremendous work in the field of AI for retinal diseases, with age-related macular degeneration being at the top of the most studied conditions. The purpose of the current systematic review was to identify and evaluate, in terms of strengths and limitations, the articles that apply AI to optical coherence tomography (OCT) images in order to predict the future evolution of age-related macular degeneration (AMD) during its natural history and after treatment in terms of OCT morphological structure and visual function. After a thorough search through seven databases up to 1 January 2022 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 1800 records were identified. After screening, 48 articles were selected for full-text retrieval and 19 articles were finally included. From these 19 articles, 4 articles concentrated on predicting the anti-VEGF requirement in neovascular AMD (nAMD), 4 articles focused on predicting anti-VEGF efficacy in nAMD patients, 3 articles predicted the conversion from early or intermediate AMD (iAMD) to nAMD, 1 article predicted the conversion from iAMD to geographic atrophy (GA), 1 article predicted the conversion from iAMD to both nAMD and GA, 3 articles predicted the future growth of GA and 3 articles predicted the future outcome for visual acuity (VA) after anti-VEGF treatment in nAMD patients. Since using AI methods to predict future changes in AMD is only in its initial phase, a systematic review provides the opportunity of setting the context of previous work in this area and can present a starting point for future research.
Identifiants
pubmed: 37510207
pii: diagnostics13142464
doi: 10.3390/diagnostics13142464
pmc: PMC10378064
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
ID : PN-III-P2-2.1-PED-2021-2709
Références
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5428-5431
pubmed: 33019208
IEEE Trans Med Imaging. 2019 Apr;38(4):1037-1047
pubmed: 30346281
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Ophthalmology. 2018 Apr;125(4):537-548
pubmed: 29103793
Br J Ophthalmol. 2020 Dec;104(12):1735-1740
pubmed: 32217538
EClinicalMedicine. 2021 May 08;35:100875
pubmed: 34027334
NPJ Digit Med. 2018 Aug 28;1:39
pubmed: 31304320
Ophthalmology. 2013 Oct;120(10):2035-41
pubmed: 23706946
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3240-3248
pubmed: 28660277
Graefes Arch Clin Exp Ophthalmol. 2021 Nov;259(11):3261-3269
pubmed: 34097114
Ophthalmol Retina. 2018 Jan;2(1):24-30
pubmed: 31047298
PLoS One. 2023 Apr 6;18(4):e0284060
pubmed: 37023082
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4347-52
pubmed: 18566455
Prog Retin Eye Res. 2018 Nov;67:1-29
pubmed: 30076935
PLoS Med. 2007 Mar 27;4(3):e78
pubmed: 17388659
Ophthalmology. 2018 Jul;125(7):1028-1036
pubmed: 29454659
Transl Vis Sci Technol. 2021 Jun 1;10(7):30
pubmed: 34185055
Sci Rep. 2020 Sep 22;10(1):15434
pubmed: 32963300
J Med Syst. 2021 Nov 2;45(12):105
pubmed: 34729675
Med Image Anal. 2021 Feb;68:101893
pubmed: 33260118
Transl Vis Sci Technol. 2021 Nov 1;10(13):18
pubmed: 34767623
Eye (Lond). 2022 May;36(5):994-1004
pubmed: 33958739
Ophthalmology. 2014 Feb;121(2):535-44
pubmed: 24211172
Sci Robot. 2019 Dec 18;4(37):
pubmed: 33137719
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3199-3208
pubmed: 29971444
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT1-OCT13
pubmed: 27409459
Clin Ophthalmol. 2023 Jan 23;17:321-327
pubmed: 36741078
Transl Vis Sci Technol. 2020 Feb 18;9(2):11
pubmed: 32704417
IEEE J Biomed Health Inform. 2020 Dec;24(12):3456-3465
pubmed: 32750929
Lancet. 2022 Feb 19;399(10326):729-740
pubmed: 35085502
JAMA Ophthalmol. 2017 Mar 1;135(3):268-273
pubmed: 28114653
Retina. 2021 Mar 1;41(3):572-580
pubmed: 32568984
Ophthalmology. 2016 Aug;123(8):1737-1750
pubmed: 27262765
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):712-722
pubmed: 30786275
Transl Vis Sci Technol. 2020 Sep 09;9(2):51
pubmed: 32974088
Lancet Digit Health. 2021 Jan;3(1):e51-e66
pubmed: 33735069
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Ophthalmol Retina. 2021 Jul;5(7):604-624
pubmed: 33971352
Nat Med. 2020 Jun;26(6):892-899
pubmed: 32424211